期刊文献+

乳腺癌组织HER-2表达与患者年龄及腋淋巴结转移相关性的研究 被引量:10

Relationship between HER-2 expression and age and axillary lymph nodes status in breast cancer
下载PDF
导出
摘要 目的:探讨乳腺癌HER-2表达与患者年龄和腋淋巴结情况的关系。方法:采用免疫组化SP法对3994例乳腺癌患者进行ER、PR、HER-2、p53和PCNA检测。中位随访时间42个月。结果:HER-2过表达阴性(-)2930例(73.4%),阳性1064例(26.6%),其中弱阳性(++)621例(15.5%),强阳性(+++)443例(11.1%)。HER-2过表达在腋淋巴结阴性者中占24.3%,在腋淋巴结阳性者中占29.6%,其中1~3个淋巴结阳性者中占27.3%,4~9个淋巴结阳性者中占32.9%,〉10个淋巴结阳性者中占33.7%。HER-2表达与年龄呈负相关,P=0.035;与腋淋巴结转移数目呈正相关,P=0.001。HER-2表达与局部复发和区域转移无关,与远处转移呈正相关,P=0.006;腋淋巴结状况与复发转移呈正相关,P=0.001;年龄与复发转移无关。结论:年龄和腋淋巴结转移情况是HER-2表达的独立影响因素,HER-2过表达患者发生远处转移的危险性相对增高。 OBJECTIVE: To observe the relationship between HER-2 expression and age and axillary lymph nodes status in breast cancer. METHODS: Expressions of ER,PR, HER-2,p53 and PCNA were measured by immunohistochemistry (IHC). The median follow-up time was 42 months. RE- SULTS: HER-2 was overexpressed in 1 064 cases (26.6%), with (++) 621 cases (16.6%) and (+++) 443 cases 11.1%. HER-2 overexpression was 24.3% in node-negative and 29.6% in node-positive cases, and among the node-posi- tive cases, node-positive from 1 to 3 being 27.3%, node-posi- tive from 4 to 9 being 32.9%, and node-positive over 10 being 33.7%. The expression of HER-2 was positively correlated with axillary lymph nodes status (P= 0. 001), and negatively correlated with age (P=0.036). HER-2 had no correlation with tumor recurrence and regional-metastasis, but positive correlation with distance-metastasis (P = 0. 006). CONCLUSIONS: Axillary lymph nodes status and age could be taken as independent factors for HER-2 overexpression. HER-2 overexpression has potential influence on distance-metastasis.
出处 《中华肿瘤防治杂志》 CAS 2008年第6期447-449,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤/病理学 基因 HER-2 相关性 免疫组织化学 breast neoplasms/pathology genes, HER-2 correlation immunohistochemistry
  • 相关文献

参考文献8

  • 1Fitzgibbons P L, Page D L, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999[J]. Arch Pathol Lab Med, 2000,124:966-978.
  • 2Di Fiore P P, Pierce J H, Fleming T P, et al. Overexpression of the human EGF receptor confers an EDF-dependent transformed phenotypetoNIH 3T3 cells[J]. Cell, 1987, 51: 1063-1070.
  • 3Chong D, Cooke T G, Reeves J R, et al. Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer[J]. Eur J Cancer, 1999, 35(Suppl. 4) :S203.
  • 4Slamon D J, GodolPhin W, Jones L A, et al. Studies of the HER-2/neu Proto-oncogene in human breast and ovarian cancer [J]. Science, 1989, 244(4905): 707-712.
  • 5Hynes N E, Stern D F. The biology of erbB-2/neu/HER-2 and its role in cancer[J]. Bioehim BioPhys Aeta, 1994, 1198(2-3) : 165-184.
  • 6Fitzgibbons P L, Page D L, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999[J]. Arch Pathol Lab Med, 2000,124: 966-978.
  • 7Clark G M, McGuire W L. Prognostic factors in primary breast cancer[J]. Breast Cancer Res Treat, 1983, 3: S69-S72.
  • 8Piccart M J, Di Leo A, Hamilton A. HER-2 ; a predictive factor ready to use in the daily management of breast cancer patients [J]. Eur J Cancer, 2000, 36: 1755-1761.

同被引文献99

  • 1曾艳,朱润庆,马华玲,夏和顺,夏东,黄娟.非小细胞肺癌组织中Skp2的表达及其与p27^(kip1)和Ki-67蛋白表达的关系[J].中华肿瘤防治杂志,2006,13(2):93-96. 被引量:7
  • 2丁锦辉,黄先国,于冰,孙国辉.新疆维吾尔族女性乳腺癌临床病理特点与预后分析[J].肿瘤研究与临床,2006,18(8):550-552. 被引量:17
  • 3Hankins C L, Friedman J. A 7 year experience in Utilizing the latissimus dorsi myocutaneous flap for bilateral breast reeonstruction[J]. Ann Plast Surg, 2008, 60(2): 134-140.
  • 4Saulis A S, Mustoe T A, Fine N A. A retrospective analysis of patient satisfaction with immediate postmastectomy breast reconstruction: comparison of three common procedures[J]. Plast Re constr Surg, 2007, 119(6): 1669-1676.
  • 5Hartrampf C R, Sheflan M, Black P W. Breast reconstruction with a transverse abdominal island flap[J].Plast Reconstr Surg, 1982, 69(2): 216-224.
  • 6Nahabedian M Y, Manson P N. Contour abnormalities of the abdomen after transverse rectus abdominis muscle flap breast reconstruction: a muhifactorial analysis[J].Plast Reconstr Surg, 2002, 109(1) : 81-87.
  • 7Kroll S S. Midline fascial preservation in double-pedicle TRAM flap breast reconstruction[J]. Ann Plast Reconstr Surg, 1989, 23(2) : 104-111.
  • 8Hartrampf C R. Abdominal wall competence in transverse abdominal island flap operations[J]. Ann Plast Surg, 1984,12(2):139-146.
  • 9Kross S S, Schusterman M, Reece G P. Abdominal wall strength, bulging, and hernia after TRAM flap breast reconstruetion[J]. Plast Reconstr Surg, 1995, 96(3):616-619.
  • 10Gill P S, Hunt JP, Guerra A B, et al. A 10-year restrospective review of 758 DIEP flaps for breast reconstruetion[J].Plast Reconstr Surg, 2004, 113(4):1153-1160.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部